Drug resistant tuberculosis in Estonia

International Journal of Tuberculosis and Lung Disease

Volumn 2, Issue 2, 1998, Pages 130-133

  Kruuner, A ^a   Sillastu, H ^a   Danilovitsh, M ^a   Levina, K ^b   Svenson, S B ^c   Kallenius G ^d   Hoffner, S E ^d  

^a TARTU UNIVERSITY HOSPITAL   (Estonia)

^b Kivimae Hospital   (Estonia)

^c SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^d SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

Drug resistance; Estonia; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ARTICLE; ESTONIA; HEALTH CARE QUALITY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; RELAPSE; STRAIN DIFFERENCE; TUBERCULOSIS;

ADULT; ANTITUBERCULAR AGENTS; DRUG RESISTANCE, MICROBIAL; ESTONIA; FEMALE; HUMANS; INCIDENCE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROSPECTIVE STUDIES; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 0031929351     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Dolin P J, Raviglione M C, Kochi A. Global tuberculosis incidence and mortality during 1990-2000. Bull World Health Organ 1994; 72: 213-220.
2. Kochi A. The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle 1991; 72: 1-6.
3. Tuberculosis control and research strategies for the 1990s: memorandum from a WHO meeting. Bull World Health Organ 1992; 70: 17-21.
4. Culliton B J. Drug resistant TB may bring epidemic. Nature 1992, 356. 473.
5. Manalo F, Tan F, Sharbaro J A, Iseman M D. Community-based short-course treatment of pulmonary tuberculosis in a developing nation. Am Rev Respir Dis 1990; 142: 1301-1305.
6. Rodier G, Gravier P, Sevre J P, Binson G, Omar C S. Multidrug-resistant tuberculosis in the horn of Africa. J Infect Dis 1993; 168: 523-524.
7. Ravighone M C, Rieder H L, Styblo K, Khomenko A G, Esteves K, Kochi A. Tuberculosis trends in Eastern Europe and the former USSR. Tubercle Lung Dis 1994; 75: 400-416.
8. Hoffner S E, Svenson S B, Norberg R, Dias F, Ghebremichael S, Kállenius G. Biochemical heterogeneity of Mycobacterium tuberculosis complex isolates in Guinea Bissau. J Clin Microbiol 1993; 31: 2215-2217.
9. Canetti G, Fox W, Khomenko A, et al. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ 1969; 41: 21-43.
10. Siddiqi S H, Libonati J P, Middlebrook G. Evaluation of a rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol 1981; 13: 908-913.
11. Hoffner S E, Kallenius G. Susceptibility of streptomycin-resistant Mycobacterium tuberculosis strains to amikacin. Eur J Clin Microbiol Infect Dis 1988; 7: 188-190.
12. Laszlo A, Rahman M, Raviglione M, Bustreo F, WHO/IUATLD Network of Supranational Reference Laboratories. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD supranational laboratory network: first round of proficiency testing. Int J Tuberc Lung Dis 1997; 1: 231-238.
13. Hoffner S E, Kallenius G, Kruuner A, Sillastu H, Pruunsild T. Some data on drug resistant tuberculosis in Estonia. Tubercle Lung Dis 1994. Suppl 1: 21, abstract 72
14. The Swedish Tuberculosis Index, 1995. Swedish Institute for Infectious Disease Control, Stockholm, Sweden.
15. Gangadharam P R J. Drug resistance in tuberculosis: it's not always the patient's Fault. Tubercle Lung Dis 1993; 74: 64-67.